Device Trial Radar · NCT01520324
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
Last checked: Nov 19, 2026Latest source record: Feb 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Jan 2012
Primary completion
Jul 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- Cosmo Technologies LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluation of the intraepithelial neoplasia detection rate in patients with long standing ulcerative colitis undergoing mucosal staining with oral methylene blue MMX tablets prior to colonoscopy.
Conditions
- Ulcerative Colitis
Interventions
oral delivery mucosal stainDevice
200mg methylene blue MMX tablet taken prior to colonoscopy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Detected Intraepithelial NeoplasiaTime frame: During colonscopy (usually <15 min) and subsequent histological analysis
- Intraepithelial Neoplasia (IN) Detection Rate (True Positive Findings)Time frame: During colonscopy (usually <15 min) and subsequent histological analysis
- Intraepithelial Neoplasia (IN) Detection Rate (False Positive Findings)Time frame: During colonscopy (usually <15 min) and subsequent histological analysis
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centre for Research & Care of Intestinal Diseases
Rozzano, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.